阿托伐他汀治疗冠心病合并高血脂的临床疗效观察  

Clinical Efficacy of Atorvastatin Treatment of Coronary Heart Disease and High Cholesterol

作　　者：高秋[1] 杨松[1] 陈燕春[1] 周维[1] 

机构地区：[1]江苏省宜兴市人民医院心血管内科,214200

出　　处：《中国卫生标准管理》2015年第33期102-103,共2页China Health Standard Management

摘　　要：目的探析阿托伐他汀治疗冠心病合并高血脂的临床疗效。方法选取2013年3月~2015年8月收治的100例冠心病合并高血脂患者,随机分为治疗组和对照组,各50例,治疗组采取阿托伐他汀治疗;对照组采取瑞舒伐他汀;比较两组治疗效果及不良反应情况。结果治疗组总有效率92.0%高于对照组72.0%,比较差异有统计学意义,P〈0.05;治疗组不良反应发生率8.0%低于对照组20.0%,比较差异有统计学意义,P〈0.05。结论阿托伐他汀治疗冠心病合并高血脂安全有效,应用价值好。Objective Analysis of clinical efficacy of atorvastatin treatment of coronary heart disease and high cholesterol. Methods From March 2013 ~ August 2015,100 cases of coronary heart disease and high cholesterol were randomly divided into treatment group and the control group,50 patients in each group, the treatment group received atorvastatin,the control group received rosuvastatin; Compared two therapeutic effects and adverse reactions.Results The total efficiency in treatment group 92.0% was higher than 72.0% in control group, the difference was significant P〈0.05; The adverse reaction rate in treatment group 8.0% was significantly lower than 20.0% in the control group was, the difference was significant P〈0.05. ConclusionAtorvastatin treatment of coronary heart disease and high cholesterol is safe and effective.

关 键 词：阿托伐他汀 冠心病 高血脂 

分 类 号：R589.2[医药卫生—内分泌]